Cevdet Samikoglu, Biosplice CEO
February 8, 2022 09:47 AM EST
People

Bios­plice, a for­mer an­ti-ag­ing uni­corn, slash­es staff in lat­est episode of its long fall from grace

Kyle Blankenship

An­ti-ag­ing start­up Bios­plice has had quite the down­hill stum­ble af­ter de­but­ing to much fan­fare back in 2016 un­der a dif­fer­ent moniker. Now, the biotech is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times